Japan Continues to Use Vaccines, Not Ivermectin, to Fight COVID-19
SciCheck Digest
More than 70% of Japan’s population has received the COVID-19 vaccines, and the government is moving ahead with a booster shot in December. But a conservative radio host in the U.S. falsely claimed, “Japan drops vax rollout, goes to Ivermectin.” Japan hasn’t stopped its vaccine program and hasn’t approved ivermectin as a COVID-19 treatment.
All of the authorized and approved vaccines are effective at preventing symptomatic disease.
The Pfizer/BioNTech vaccine, which is the first COVID-19 vaccine to receive full approval from the Food and Drug Administration, showed a final efficacy of 91% against symptomatic illness in its phase 3 trial, meaning that under the conditions of the trial the vaccine reduced the risk of getting sick by 91%. The Moderna vaccine showed similar results in its clinical trial, with an efficacy of 94% against disease at the time of emergency use authorization.
Johnson & Johnson, which partly tested its vaccine in South Africa when the emerged, an efficacy of 66% in preventing moderate to severe COVID-19 and an efficacy of
You’re reading a preview, subscribe to read more.
Start your free 30 days